News Life and Health17 Nov 2026

China:National catalogue of medicines covered under medical insurance now includes more innovative drugs

| 17 Nov 2026

China has updated the list of drugs available under its national medical insurance drug list and the commercial insurance innovative drug list. The commercial insurance innovative drug list was introduced in December 2025.

The National Healthcare Security Administration (NHSA) released the updated lists on 14 November 2026. A news report by news agency Xinhua said the NHSA has added a total of 107 drugs were added to the updated national catalogue of medicines covered by medical insurance, including 51 Class 1 innovative drugs not yet marketed in China or overseas, setting a new record.  

The news report quoting the NHSA said the newly added medicines address urgent clinical needs in several areas including cancer, rare diseases, chronic conditions and mental health disorders, said the administration.

The commercial insurance innovative drug list has been enhanced with the addition of 12 medicines, bringing the total to 28. The administration noted that these medicines include the world's first CAR-T therapy for solid tumours and China's first gene therapy for haemophilia. The two revised lists will take effect on 1 January 2027.

The NHSA was established in 2018 and since then it has made nine adjustments to the catalogue of medicines covered by medical insurance. Following the latest adjustment, the catalogue now includes 3,331 medicines, covering both Western and traditional Chinese medicine.

| Print

CAPTCHA image
Enter the code shown above in the box below.

Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.

 

Recent Comments

There are no comments submitted yet. Do you have an interesting opinion? Then be the first to post a comment.


Other News



Follow Asia Insurance Review